Margao: Goa-based diagnostic company Molbio Diagnostics has received the Indian Council of Medical Research’s (ICMR) approval for allowing its testing kit, the Truenat Beta CoV test, to be used for testing the presence of coronavirus.
The ICMR’s department of health research on Friday issued a statement stating that the testing kit developed by the company has been validated and recommended as a screening test.
The approval makes Molbio Diagnostics the second Indian-based manufacturer to be given validation for its testing kit.
Speaking about the achievement, Sumit Mitra, president, global sales and marketing of Molbio Diagnostics (P) Limited, said the test will aim to ease the workload of laboratories working to test for the virus.
“The patented Truenat Beta CoV test based on the Taqman RTPCR (Real Time Reverse Transcription Polymerase Chain Reaction) chemistry and assayed on the Patented Truelab Real Time micro PCR platform will deliver a patient’s result in just under an hour. With over 800 installations of the platform already in India and another 1,500-odd having been ordered by the government of India under the NTEP (National Tuberculosis Elimination Programme), the testing for COVID-19 on the Molbio platform can now be expected to ease the workload of central laboratories, arising from the current COVID-19 pandemic,” he said.
The chip-based molecular diagnostics test using PCR technology will first extract nucleic acids from human throat and nasal swab specimen, blood or plasma, which will then be tested on a chip along with other reagents and then run through a micro PCR analyser.
The company has its manufacturing and marketing facility at the Verna industrial estate.